S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.20%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
Top-Rated Stocks  
NYSE:BSX

Boston Scientific - BSX Stock Forecast, Price & News

$48.83
+0.88 (+1.84%)
(As of 03/20/2023 04:22 PM ET)
Add
Compare
Today's Range
$47.93
▼
$48.85
50-Day Range
$45.09
▼
$48.50
52-Week Range
$34.98
▼
$48.87
Volume
8.99 million shs
Average Volume
7.61 million shs
Market Capitalization
$70.06 billion
P/E Ratio
108.51
Dividend Yield
N/A
Price Target
$51.50

Boston Scientific MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.9% Upside
$51.50 Price Target
Short Interest
Healthy
0.88% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.98
Upright™ Environmental Score
News Sentiment
0.25mentions of Boston Scientific in the last 14 days
Based on 29 Articles This Week
Insider Trading
Selling Shares
$5.43 M Sold Last Quarter
Proj. Earnings Growth
13.16%
From $1.90 to $2.15 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

271st out of 983 stocks

Surgical & Medical Instruments Industry

24th out of 101 stocks

See Top Rated MarketRank™ Stocks Here

BSX stock logo

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Stock News Headlines

March 20, 2023 | msn.com
Boston City Council to discuss proposed ban on 'nips'
March 19, 2023 | msn.com
Zdeno Chara to run Boston Marathon for Team Hoyt, Thomas E. Smith Foundation
March 20, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
March 19, 2023 | msn.com
South Boston’s St. Patrick’s day breakfast serves up barbs for the departed
March 19, 2023 | msn.com
Boston man accused of trying to throw ‘imposter’ wife into Fort Point Channel
March 19, 2023 | msn.com
Boston weather: Here’s what to expect from Monday’s forecast
March 19, 2023 | msn.com
South Boston residents, tourists, and businesses gear up for St. Patrick's Day Parade
March 19, 2023 | msn.com
Parade day in Boston: Everything you need to know
March 20, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
March 19, 2023 | msn.com
MBTA ramps up service for St. Patrick's Day Parade in Boston
March 19, 2023 | americanbankingnews.com
StockNews.com Begins Coverage on Boston Scientific (NYSE:BSX)
March 18, 2023 | msn.com
Boston man accused of attempting to throw 'imposter' wife into Fort Point Channel
March 18, 2023 | msn.com
Boston police ask for public’s help in locating missing 14-year-old
March 18, 2023 | sportsbookwire.usatoday.com
Boston Bruins vs. Minnesota Wild odds, tips and betting trends
March 18, 2023 | msn.com
Boston man threatens subway riders with pet rat Jerry: Police
March 18, 2023 | nasdaq.com
BSX November 17th Options Begin Trading
March 18, 2023 | celticswire.usatoday.com
Boston Celtics vs. Portland Trail Blazers odds, tips and betting trends | March 17
March 18, 2023 | msn.com
Former WBZ employees tied to Boston Strangler speak out as new movie is released
March 18, 2023 | finance.yahoo.com
Boston Scientific Corporation (NYSE:BSX) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
March 17, 2023 | msn.com
Boston Strangler Cast: Where You've Seen The Actors From The Hulu True Crime Thriller
March 17, 2023 | msn.com
$100,000 salary in Boston feels like $46,000, according to study
March 15, 2023 | marketwatch.com
Boston Scientific Corp. stock falls Wednesday, underperforms market
March 15, 2023 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) Receives $51.50 Consensus Target Price from Analysts
March 13, 2023 | marketwatch.com
Boston Scientific Corp. stock outperforms market on strong trading day
March 10, 2023 | msn.com
Looking Into Boston Scientific's Recent Short Interest
March 8, 2023 | finance.yahoo.com
Boston Scientific: Three of My Teachable Moments on Embracing Equity
March 7, 2023 | finance.yahoo.com
Boston Scientific Corporation (NYSE:BSX) insiders sold US$3.5m worth of stock suggesting impending weakness.
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings
2/01/2023
Today
3/20/2023
Next Earnings (Estimated)
4/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BSX
CUSIP
10113710
CIK
885725
Web
www.bostonscientific.com
Phone
(508) 683-4000
Fax
508-683-5675
Employees
45,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$51.50
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+5.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.45
Trailing P/E Ratio
108.05
Forward P/E Ratio
25.59
P/E Growth
2.26
Net Income
$698 million
Net Margins
5.50%
Pretax Margin
9.00%
Return on Equity
14.29%
Return on Assets
7.67%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
1.51
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$12.68 billion
Price / Sales
5.50
Cash Flow
$2.64 per share
Price / Cash Flow
18.43
Book Value
$12.27 per share
Price / Book
3.96

Miscellaneous

Outstanding Shares
1,434,780,000
Free Float
1,424,593,000
Market Cap
$69.76 billion
Optionable
Optionable
Beta
0.79

Social Links


Key Executives

  • Michael F. MahoneyMichael F. Mahoney
    Chairman, President & Chief Executive Officer
  • John Bradley SorensonJohn Bradley Sorenson
    Executive Vice President-Global Operations
  • Daniel J. BrennanDaniel J. Brennan
    Chief Financial Officer & Executive Vice President
  • Jodi Eddy
    Senior VP, Chief Information & Digital Officer
  • Ian T. MeredithIan T. Meredith
    Global Chief Medical Officer & Executive VP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 1 hold rating, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.

What is Boston Scientific's stock price forecast for 2023?

14 equities research analysts have issued 12 month price targets for Boston Scientific's shares. Their BSX share price forecasts range from $43.00 to $56.00. On average, they predict the company's share price to reach $51.50 in the next year. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2023?

Boston Scientific's stock was trading at $46.27 at the start of the year. Since then, BSX shares have increased by 5.5% and is now trading at $48.83.
View the best growth stocks for 2023 here.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 12,690,000 shares, an increase of 29.9% from the February 13th total of 9,770,000 shares. Based on an average trading volume of 6,880,000 shares, the days-to-cover ratio is currently 1.8 days.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our BSX earnings forecast.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) issued its earnings results on Wednesday, February, 1st. The medical equipment provider reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by $0.02. The medical equipment provider had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.24 billion. Boston Scientific had a trailing twelve-month return on equity of 14.29% and a net margin of 5.50%. The firm's revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company earned $0.45 EPS.
Read the conference call transcript.

What ETFs hold Boston Scientific's stock?

ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), Goldman Sachs Future Health Care Equity ETF (GDOC), Global X Aging Population ETF (AGNG), Invesco Dynamic Market ETF (PWC), BlackRock Future Health ETF (BMED), Putnam Sustainable Leaders ETF (PLDR), First Trust Indxx Medical Devices ETF (MDEV) and Strategy Shares Halt Climate Change ETF (NZRO).

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its FY23 earnings guidance on Wednesday, February, 1st. The company provided EPS guidance of $1.86-1.93 for the period, compared to the consensus EPS estimate of $1.93. The company issued revenue guidance of ~$13.32-13.57 billion, compared to the consensus revenue estimate of $13.45 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.74%), Bollard Group LLC (1.71%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (1.63%), Artisan Partners Limited Partnership (1.36%), Moneta Group Investment Advisors LLC (1.30%) and Amundi (1.00%). Insiders that own company stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Wendy Carruthers and William F Bruss.
View institutional ownership trends.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $48.83.

How much money does Boston Scientific make?

Boston Scientific (NYSE:BSX) has a market capitalization of $70.06 billion and generates $12.68 billion in revenue each year. The medical equipment provider earns $698 million in net income (profit) each year or $0.45 on an earnings per share basis.

How many employees does Boston Scientific have?

The company employs 45,000 workers across the globe.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 3/20/2023 by MarketBeat.com Staff